Literature DB >> 16126568

Clinical significance of Acinetobacter species isolated from cerebrospinal fluid.

Hsin-Pai Chen1, Chung-Hsu Lai, Yu-Jiun Chan, Te-Li Chen, Chun-Yu Liu, Chang-Phone Fung, Cheng-Yi Liu.   

Abstract

Medical records of 54 patients whose cerebrospinal fluid (CSF) cultures were positive for Acinetobacter were retrospectively reviewed. In 34 (63.0%) patients, the Acinetobacter isolates were clinically insignificant. In the other 20 (37.0%) patients, presence of the organism was regarded as clinically significant and specific antimicrobial therapy was administered. Patients with clinically significant Acinetobacter in CSF more frequently resided in intensive care units (p = 0.011), had intracerebral hemorrhage (p = 0.012) or previous CNS infection (p = 0.003), had prior antibiotic exposure (p = 0.011), and had undergone neurosurgical procedures (p = 0.003). Their CSF was characteristic of neutrophilic pleocytosis, an elevated protein level, and a low CSF-to-serum glucose ratio. Apart from fever, no significant statistical differences existed in individual clinical symptoms and signs between the 2 groups of patients, while a combination of symptoms efficiently differentiated clinically significant and insignificant Acinetobacter. The finding of multiple CSF specimens positive for Acinetobacter was highly suggestive of an active CNS infection (p<0.001). The high ratio of clinically insignificant Acinetobacter CSF isolates highlights the importance of careful judgment when the organism is cultured from CSF. Antimicrobial therapy must be initiated promptly in patients with identified risk factors, while unnecessary treatment should be avoided in those without them.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126568     DOI: 10.1080/00365540510044076

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Molecular epidemiology and the clinical significance of Acinetobacter baumannii complex isolated from cerebrospinal fluid in neurosurgical intensive care unit patients.

Authors:  G Bayramoglu; S Kaya; Y Besli; E Cakır; G Can; O Akıneden; F Aydin; I Koksal
Journal:  Infection       Date:  2011-10-29       Impact factor: 3.553

3.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 4.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

5.  Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii.

Authors:  Dom Mahoney; David Porter; Mahableshwar Albur
Journal:  IDCases       Date:  2017-11-21

6.  Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study.

Authors:  Dahraoui Souhail; Belefquih Bouchra; Badia Belarj; Rar Laila; Frikh Mohammed; Oumarou Mamane Nassirou; Ibrahimi Azeddine; Charki Haimeur; Abdelhay Lemnouer; Mostafa Elouennass
Journal:  Case Rep Infect Dis       Date:  2016-03-15

7.  Acute blindness in a dog with Acinetobacter-associated postencephalitic hydrocephalus.

Authors:  Jung-Hyun Kim; Ji-Hee Jeon; Kang-Hyo Park; Hun-Young Yoon; Joon-Young Kim
Journal:  J Vet Med Sci       Date:  2017-08-28       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.